MSB 3.19% 97.0¢ mesoblast limited

A summary of information submitted as part of the...

  1. 2,680 Posts.
    lightbulb Created with Sketch. 1725
    • A summary of information submitted as part of the application.
    • Information on the applicant submitting the biologics license application.
    • A preclinical data section.
    • A clinical data section that includes safety and efficacy data on the product.
    • Draft labeling of the product to be licensed.
    • Information on the manufacturing, chemistry, and controls of the product.
    • A data summary of validation of important processes and assays involved in the manufacture of the product.
    • A description of the facility where the product is manufactured.
    • Case report form tabulations on the manufacturer’s clinical experience with the product.
    • Case report forms and serious event narratives.
    • An index.


    This is what we submit for a BLA

    Safety efficacy and manufacturing ticked off.

    if it's accepted it won't take long


    Reg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.